The Stock for 1999(Polymedica)PLMD(Medical Supply Co.) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The Stock for 1999(Polymedica)PLMD(Medical Supply Co.)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Abuckatatime who wrote (2200)	11/13/1998 7:23:00 PM
From: Abuckatatime	Read Replies (3) of 3414

"Significantly undervalued and actively overlooked." That's how Josephthal & Co. analyst Sharon di Stefano describes PM's shares in her Nov. 6 update on the company. Quoting from that report - "PM trades at a 28% discount to the median multiple of a peer group composed of consumer medical products and services companies and at more than a 40% discount to the S&P 500." Josephthal projects Liberty revenue growth of approx. 50% this fiscal year vs. last, and approx. 30% for FY2000 vs. FY1999. EPS estimates for '99 and '00 are $0.66 and $0.85. Twelve month price target per this latest report is $16.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next